Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy

Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy

Immunotherapy is offering patients with cancer new therapy options. Here, the authors report on the crystal structures of some of these therapies bound to their targets.

Bibliographic Details
Main Authors: Ju Yeon Lee, Hyun Tae Lee, Woori Shin, Jongseok Chae, Jaemo Choi, Sung Hyun Kim, Heejin Lim, Tae Won Heo, Kyeong Young Park, Yeon Ji Lee, Seong Eon Ryu, Ji Young Son, Jee Un Lee, Yong-Seok Heo
Format: Article
Language:English
Published: Nature Publishing Group 2016-10-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/ncomms13354

Internet

https://doi.org/10.1038/ncomms13354

Similar Items